Bethesda system

From WikiMD.org
Jump to navigation Jump to search

Bethesda System

The Bethesda System (pronounced: beth-es-da system) is a system for reporting cervical or vaginal cytologic diagnoses, used for reporting Pap smear results. It was introduced in 1988 and revised in 1991, 2001 and 2014. The name comes from the location (Bethesda, Maryland) of the conference that established the system.

Etymology

The term "Bethesda System" originates from the city of Bethesda in Maryland, United States, where the National Institutes of Health is located. The system was first developed at a conference held in this city in 1988.

Description

The Bethesda System classifies the results of Pap smear tests into several categories. These categories include:

  • Negative for Intraepithelial Lesion or Malignancy: This means the cells appear normal.
  • Epithelial Cell Abnormalities: This includes several subcategories, such as Atypical Squamous Cells of Undetermined Significance (ASC-US), Low-Grade Squamous Intraepithelial Lesion (LSIL), and High-Grade Squamous Intraepithelial Lesion (HSIL).
  • Other Malignant Neoplasms: This category includes endometrial cells in women over 40, which could indicate endometrial cancer.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski